129 related articles for article (PubMed ID: 38029714)
1. Involvement of osteopontin, EpCAM, estrogen receptor-alpha, and carbonic anhydrase IX protein in managing lung cancer via Berberine-loaded liquid crystalline nanoparticles.
De Rubis G; Paudel KR; Allam VSRR; Malyla V; Subramaniyan V; Singh SK; Panth N; Gupta G; Hansbro PM; Chellappan DK; Dua K
Pathol Res Pract; 2024 Jan; 253():154971. PubMed ID: 38029714
[No Abstract] [Full Text] [Related]
2. Carbonic anhydrase IX-directed immunoliposomes for targeted drug delivery to human lung cancer cells in vitro.
Wong BC; Zhang H; Qin L; Chen H; Fang C; Lu A; Yang Z
Drug Des Devel Ther; 2014; 8():993-1001. PubMed ID: 25092965
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary delivery of triptolide-loaded liposomes decorated with anti-carbonic anhydrase IX antibody for lung cancer therapy.
Lin C; Wong BCK; Chen H; Bian Z; Zhang G; Zhang X; Kashif Riaz M; Tyagi D; Lin G; Zhang Y; Wang J; Lu A; Yang Z
Sci Rep; 2017 Apr; 7(1):1097. PubMed ID: 28428618
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers.
Le QT; Chen E; Salim A; Cao H; Kong CS; Whyte R; Donington J; Cannon W; Wakelee H; Tibshirani R; Mitchell JD; Richardson D; O'Byrne KJ; Koong AC; Giaccia AJ
Clin Cancer Res; 2006 Mar; 12(5):1507-14. PubMed ID: 16533775
[TBL] [Abstract][Full Text] [Related]
5. A pilot study on potential plasma hypoxia markers in the radiotherapy of non-small cell lung cancer. Osteopontin, carbonic anhydrase IX and vascular endothelial growth factor.
Ostheimer C; Bache M; Güttler A; Kotzsch M; Vordermark D
Strahlenther Onkol; 2014 Mar; 190(3):276-82. PubMed ID: 24322994
[TBL] [Abstract][Full Text] [Related]
6. Safety and proof-of-concept efficacy of inhaled drug loaded nano- and immunonanoparticles in a c-Raf transgenic lung cancer model.
Karra N; Nassar T; Laenger F; Benita S; Borlak J
Curr Cancer Drug Targets; 2013 Jan; 13(1):11-29. PubMed ID: 23030233
[TBL] [Abstract][Full Text] [Related]
7. Berberine-loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro.
Paudel KR; Mehta M; Yin GHS; Yen LL; Malyla V; Patel VK; Panneerselvam J; Madheswaran T; MacLoughlin R; Jha NK; Gupta PK; Singh SK; Gupta G; Kumar P; Oliver BG; Hansbro PM; Chellappan DK; Dua K
Environ Sci Pollut Res Int; 2022 Jul; 29(31):46830-46847. PubMed ID: 35171422
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase IX is a marker of hypoxia and correlates with higher Gleason scores and ISUP grading in prostate cancer.
Ambrosio MR; Di Serio C; Danza G; Rocca BJ; Ginori A; Prudovsky I; Marchionni N; Del Vecchio MT; Tarantini F
Diagn Pathol; 2016 May; 11(1):45. PubMed ID: 27225200
[TBL] [Abstract][Full Text] [Related]
9. Expression of carbonic anhydrase IX in human pancreatic cancer.
Juhász M; Chen J; Lendeckel U; Kellner U; Kasper HU; Tulassay Z; Pastorekova S; Malfertheiner P; Ebert MP
Aliment Pharmacol Ther; 2003 Oct; 18(8):837-46. PubMed ID: 14535878
[TBL] [Abstract][Full Text] [Related]
10. PEG Linker Length Strongly Affects Tumor Cell Killing by PEGylated Carbonic Anhydrase Inhibitors in Hypoxic Carcinomas Expressing Carbonic Anhydrase IX.
Mondal UK; Doroba K; Shabana AM; Adelberg R; Alam MR; Supuran CT; Ilies MA
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498779
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma.
Vermylen P; Roufosse C; Burny A; Verhest A; Bosschaerts T; Pastorekova S; Ninane V; Sculier JP
Eur Respir J; 1999 Oct; 14(4):806-11. PubMed ID: 10573225
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase IX from cancer-associated fibroblasts drives epithelial-mesenchymal transition in prostate carcinoma cells.
Fiaschi T; Giannoni E; Taddei ML; Cirri P; Marini A; Pintus G; Nativi C; Richichi B; Scozzafava A; Carta F; Torre E; Supuran CT; Chiarugi P
Cell Cycle; 2013 Jun; 12(11):1791-801. PubMed ID: 23656776
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor 1 promotes chemoresistance of lung cancer by inducing carbonic anhydrase IX expression.
Sowa T; Menju T; Chen-Yoshikawa TF; Takahashi K; Nishikawa S; Nakanishi T; Shikuma K; Motoyama H; Hijiya K; Aoyama A; Sato T; Sonobe M; Harada H; Date H
Cancer Med; 2017 Jan; 6(1):288-297. PubMed ID: 28028936
[TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase IX in early-stage non-small cell lung cancer.
Kim SJ; Rabbani ZN; Vollmer RT; Schreiber EG; Oosterwijk E; Dewhirst MW; Vujaskovic Z; Kelley MJ
Clin Cancer Res; 2004 Dec; 10(23):7925-33. PubMed ID: 15585626
[TBL] [Abstract][Full Text] [Related]
16. N-β-glycosyl sulfamides are selective inhibitors of the cancer associated carbonic anhydrase isoforms IX and XII.
Rodríguez OM; Maresca A; Témpera CA; Bravo RD; Colinas PA; Supuran CT
Bioorg Med Chem Lett; 2011 Aug; 21(15):4447-50. PubMed ID: 21723123
[TBL] [Abstract][Full Text] [Related]
17. Development of small molecule carbonic anhydrase IX inhibitors.
Supuran CT
BJU Int; 2008 Jun; 101 Suppl 4():39-40. PubMed ID: 18430122
[No Abstract] [Full Text] [Related]
18. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase IX expression correlates with FDG uptake by primary non-small cell lung cancer.
Mees G; Vangestel C; Dierckx R; Pauwels P; Van Meerbeeck J; Van de Wiele C
Cancer Biother Radiopharm; 2010 Apr; 25(2):149-54. PubMed ID: 20423227
[TBL] [Abstract][Full Text] [Related]
20. A sucrose-binding site provides a lead towards an isoform-specific inhibitor of the cancer-associated enzyme carbonic anhydrase IX.
Pinard MA; Aggarwal M; Mahon BP; Tu C; McKenna R
Acta Crystallogr F Struct Biol Commun; 2015 Oct; 71(Pt 10):1352-8. PubMed ID: 26457530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
